Discover 958 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 958
Active & Responsive
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
for
Tachycardia, Ventricular
Location: Rochester MN, Saint Louis MO, Columbus OH, Nashville TN,
Sponsor: Varian, a Siemens Healthineers Company
Sex: All
Age: 18+
Code: NCT05765175
Recruiting
Active & Responsive
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
for
Hypertrophic Cardiomyopathy
Location: Rochester MN, Cleveland OH, Houston TX, La Jolla CA,
Sponsor: Tenaya Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05836259
Phase1, Phase2, Recruiting
Active & Responsive
Insulin and Insulin Pulses During Fasting
for
PreDiabetes
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 25 - 65
Code: NCT06424015
Recruiting
Active & Responsive
A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study
for
Multiple System Atrophy
Location: Rochester MN, Chicago IL, Kansas City KS,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 30 - 70+
Code: NCT06568237
Phase2, Recruiting
Active & Responsive
Weight Loss Through Mayo Clinic Diet
for
Obesity
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 64
Code: NCT06862375
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
for
Spontaneous Coronary Artery Dissection, Healthy
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT05699200
Recruiting
Active & Responsive
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
for
Leiomyosarcoma
Location: Rochester MN, St Louis MO, Ann Arbor MI, Nashville TN,
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis